March 15, 2023 - LotusCR.com

Pacira Biosciences Announces Positive Topline Data From Phase 3 Study of Exparel as a Single-Dose Sciatic Nerve Block in the Popliteal Fossa for Bunionectomy

June 6, 2023March 15, 2023 by Ryan Speer

Lotus Clinical Research worked closely with Pacira on this successful pivotal Phase 3 trial in bunionectomy, providing scientific consulting and conducting the study within our CRO and the ERG site network.

Pacira Biosciences Announces Positive Topline Data From Phase 3 Study of Exparel as a Single-Dose Femoral Nerve Block in the Adductor Canal for Total Knee Arthroplasty

May 30, 2023March 15, 2023 by Ryan Speer

News & Press Lotus Clinical Research worked closely with Pacira on this successful pivotal Phase 3 trial in total knee arthroplasty (TKA), providing scientific consulting and conducting the study within our CRO and the ERG site network. ERG-Lotus was able enroll this study far more rapidly than a typical TKA study, while employing a relatively … Read more